ENGS
Energys Group Ltd
$1.70
+2.41%
$53.1M
No data for this timeframe.
Vol
Market Cap$53.1M
Cap SizeMicro Cap
SEC Reports5
Recent Activity
Apr 30, 2026
SEC
Energys Group Ltd regained compliance with Nasdaq's market value of listed securities requirement (Rule 5550(b)(2)) as o
6-K — Impact 4/10
Apr 14, 2026
SEC
Energys Group Limited has implemented a dual-class share structure and amended its governing documents to grant Class B
6-K — Impact 5/10
Apr 1, 2026
SEC
Energys Group Ltd adjourned its Extraordinary General Meeting scheduled for March 30, 2026, without conducting any busin
6-K — Impact 3/10
Latest Reports
NEUTRAL
6-K
4/10
Energys Group Ltd regained compliance with Nasdaq's market value of listed securities requirement (Rule 5550(b)(2)) as o
Apr 30, 2026
NEUTRAL
6-K
5/10
Energys Group Limited has implemented a dual-class share structure and amended its governing documents to grant Class B
Apr 14, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
5 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 4 neutral. Avg impact: 5.0/10.
NEUTRAL
6-K
4/10
Energys Group Ltd regained compliance with Nasdaq's market value of listed securities requirement (R
Apr 30, 2026
NEUTRAL
6-K
5/10
Energys Group Limited has implemented a dual-class share structure and amended its governing documen
Apr 14, 2026
NEUTRAL
6-K
3/10
Energys Group Ltd adjourned its Extraordinary General Meeting scheduled for March 30, 2026, without
Apr 1, 2026
NEUTRAL
EFFECT
6/10
Energys Group Ltd has received SEC effectiveness for its Form F-1 registration, allowing it to proce
Mar 23, 2026
BEARISH
F-1
7/10
Energys Group Ltd, a UK-based energy services company, is conducting a resale registration for up to
Mar 3, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.